Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine therapy in subclinical hypothyroidism
IRCT20121001010980N4Phase 3Completed
- Sponsor
- Endocrinology and Metabolism Research Institute
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Oxidant and antioxidant balance and hs-CRP. Started Apr 2016; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on IRCT20121001010980N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121001010980N4.